Andrews Peter M, Cooper Matthew, Verbesey Jennifer, Ghasemian Seyed, Rogalsky Derek, Moody Patrick, Chen Allen, Alexandrov Peter, Wang Hsing-Wen, Chen Yu
1 Georgetown University Medical Center, Washington, DC. 2 Fischell Department of Bioengineering, University of Maryland, College Park, MD. 3 Address correspondence to: Peter M. Andrews, Ph.D., Georgetown University Medical Center, Washington, DC.
Transplantation. 2014 Oct 27;98(8):893-7. doi: 10.1097/TP.0000000000000154.
Optical coherence tomography (OCT) revealed that cells lining proximal convoluted tubules of living donor kidneys (LDKs) procured by laparoscopic procedures were very swollen in response to the brief period of ischemia experienced between the time of arterial vessel clamping and flushing the excised kidney with cold preservation solution. Damage to the tubules as a result of this cell swelling resulted in varying degrees of acute tubular necrosis (ATN) that slowed the recovery of the donor kidneys during the first 2 weeks after their transplantation.
To prevent this cell damage during LDK procurement, we changed the protocol for intravenous administration of mannitol (i.e., 12.5 or 25 g) to the donor. Specifically, we reduced the time of mannitol administration from 30 to 15 min or less before clamping the renal artery.
OCT revealed that this change in the timing of mannitol administration protected the human donor proximal tubules from normothermic-induced cell swelling. An evaluation of posttransplant recovery of renal function showed that patients treated with this modified protocol returned to normal renal function significantly faster than those treated with mannitol 30 min or more before clamping the renal artery.
Because slow graft recovery in the first weeks after transplantation represents a risk factor for long-term graft function and survival, we believe that this change in pretreatment protocol will improve renal transplants in patients receiving LDK.
光学相干断层扫描(OCT)显示,通过腹腔镜手术获取的活体供肾(LDK)近端曲管内衬细胞,在动脉血管夹闭至用冷保存液冲洗切除的肾脏这段短暂缺血期后,出现非常明显的肿胀。这种细胞肿胀导致肾小管受损,进而引发不同程度的急性肾小管坏死(ATN),延缓了供肾在移植后前两周的恢复。
为防止在获取LDK过程中出现这种细胞损伤,我们改变了给供体静脉注射甘露醇(即12.5或25克)的方案。具体而言,在夹闭肾动脉前,我们将甘露醇给药时间从30分钟缩短至15分钟或更短。
OCT显示,甘露醇给药时间的这种改变保护了人类供体近端小管免受常温诱导的细胞肿胀。对移植后肾功能恢复情况的评估表明,采用这种改良方案治疗的患者恢复至正常肾功能的速度明显快于在夹闭肾动脉前30分钟或更长时间给予甘露醇治疗的患者。
由于移植后最初几周移植物恢复缓慢是长期移植物功能和存活的一个危险因素,我们认为这种预处理方案的改变将改善接受LDK患者的肾移植情况。